5.Jorgensen, PD. Pharmaceuticals, political money, and public policy: A theoretical and empirical agenda. Journal of Law, Medicine and Ethics2013;14(3):562.
6. In considering initial prospects for change, Jorgensen, for example, has proposed “an agenda that would provide (a) a theoretical framework . . . with which to view pharmaceutical political power and (b) two empirical projects to document links between political money and pharmaceutical policy”; see note 5, Jorgensen 2013, at 565.